In mouse models of atherosclerosis, such as LDL receptor deficiency or ApoE deficiency, genetic ablation of RIPK3 reduces both advanced atherosclerotic lesions and lesional inflammation [145]. The gene discussed is RIPK3; the disease is atherosclerosis.